2016 Pharmigene obtained Korea GMP certification.
2013 Pharmigene's molecular medical lab got ISO 17025 certificate from TAF.
2012 ISO / CE IVD 2012 annual inspection was completed. GMP inspection for facility and new products was completed.
2011 ISO / CE IVD 2011 annual inspection was completed. Pharmigene's HLA-B*5801 Detection Kit got TFDA approval.
2010 ISO / CE IVD 2010 annual inspection was completed.
2009 Pharmigene obtained GMP certification. Pharmigene obtained CE Marking of Conformity-IVD。
2008 PG1502 DNA detection kit received approval from TFDA, listed in the Annex II medical device (No.002588).
2007 US FDA listing (ASR)
2006 Pharmigene obtained ISO 13485.